"We specialize in clinical research studies involving paid volunteers. Want to volunteer for a clinical trial? Check out our website to view our current studies and see if you may qualify for a trial. Carolina Institute for Clinical Research is dedicated to conducting safe and successful research studies. Clinical trials allow medical researchers to evaluate drug effectiveness and safety in a controlled environment."

During the past decade, Carolina Institute for Clinical Research conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 7 clinical trials were completed, i.e. on average, 23.3% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 7 clinical trials were completed. i.e. 29.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Institute for Clinical Research" #1 sponsor was "ModernaTX, Inc." with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Abbott Molecular" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Institute for Clinical Research" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "OSTAtistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Institute for Clinical Research" are "Influenza, Human" (2 trials), "Respiratory Syncytial Virus" (2 trials), "SARS-CoV-2 Infection" (2 trials), "COVID-19" (1 trials) and "COVID-19 Disease" (1 trials). Many other conditions were trialed in "Carolina Institute for Clinical Research" in a lesser frequency.

Most popular intervention types in "Carolina Institute for Clinical Research" are "Biological" (14 trials), "Drug" (14 trials), "Other" (7 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ad26.COV2.S" (2 trials), "mRNA-1345" (2 trials), "13vPnC" (1 trials) and "20vPnC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Institute for Clinical Research" are 24 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Carolina Institute for Clinical Research". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Carolina Institute for Clinical Research, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Institute for Clinical Research, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".